N

New Science Ventures

VC Firm·Greenwich, Connecticut, USA·$700M+ AUM

New Science Ventures (NSV) is a venture capital firm founded in 2004 by Somu Subramaniam and Tom Lavin, with offices in Greenwich, Connecticut, and London. The firm invests in early and late stage companies that leverage breakthrough science to address significant unmet needs in life sciences and information technology. Its life sciences focus covers pharmaceuticals, biologics, medical devices, and diagnostics, while its IT focus spans high-performance semiconductors, cellular infrastructure, sensor networks, and enterprise software. NSV has made 154 investments and achieved 23 portfolio exits.

Focus Areas

Life SciencesPharmaceuticalsMedical DevicesSemiconductorsSensor NetworksEnterprise Software
Visit websiteLinkedIn

Portfolio

1 company in our directory

Paragraf logo

Paragraf

Advanced Materials·Series C

Paragraf is a University of Cambridge spinout founded in 2017 by Simon Thomas (CEO), Professor Sir Colin Humphreys, and Ivor Guiney. The company commercialises graphene and other two-dimensional materials at scale using standard semiconductor fabrication equipment, with a proprietary direct deposition technique that produces device-quality graphene on 8-inch wafers without metal catalysts or transfer processes. Paragraf launched its first product in 2019, a graphene-based Hall-effect sensor offering 30x greater sensitivity than conventional silicon at one-tenth the power. The sensor portfolio has expanded to include molecular sensors for healthcare, agritech, food production, and chemical manufacturing. The company has raised over £140M across four rounds, including a $55M Series C in 2025 led by Mubadala.